Anorexia Patients Hijacked by Weight-Loss Drugs

Revolutionary weight-loss medications, initially celebrated as miracles, are proving to be a significant hindrance for individuals recovering from anorexia. AJ Jasper, a Chicago resident, shared his harrowing experience of obtaining GLP-1 prescriptions through telehealth sites by falsifying information. He found it alarmingly easy to acquire these drugs, even compounded versions, leading to a severe health crisis in January 2026.

Experts are observing a rise in anorexia patients using GLP-1s, with many obtaining them through telehealth platforms with minimal oversight. The drugs, widely used for weight loss, are making recovery difficult for those with anorexia, a complex mental health disorder affecting millions globally. A recent study indicated that over 20% of adults with eating disorders had used a GLP-1.

While telehealth platforms like Hims & Hers and Ro state they have screening processes for eating disorders, the ease of obtaining these drugs suggests gaps in the system. Some platforms require video consultations, but patients can often switch to other sites if one poses too many questions. This lack of stringent regulation has led to concerns about patient safety and the prioritization of quick prescriptions over comprehensive care.

The pervasive use of GLP-1s is impacting treatment approaches, with clinicians noting their interference in recovery programs. While the drugs may offer benefits for other eating disorders like binge eating disorder, experts universally reject their therapeutic use for anorexia. The drugs can silence the crucial hunger signals that clinicians try to address during treatment.

Jasper, now recovering, advocates for stronger safeguards around online prescribing, describing the current environment as the "wild, wild West." His petition aims to draw lawmakers' attention to the risks associated with the easy accessibility of these powerful medications for vulnerable individuals.